Successful immunotherapy and irradiation in a HIV-positive patient with metastatic Merkel cell carcinoma
Research output: Contribution to conferences › Paper › Contributed › peer-review
Contributors
Abstract
This case report presents a HIV-positive 60-year old male with Merkel cell carcinoma of his right forearm and pulmonary sarcoidosis, who, after excisions and irradiations of the primary tumour site and subsequent lymph node metastases developed distant metastases. He received radiotherapy to symptomatic mediastinal lymph node metastases followed by Doxorubicin and, after two cycles, by the PD-1 inhibitor Pembrolizumab due to mixed response. Re-staging showed a para-mediastinal, radiotherapy-induced pneumonitis, which was treated by prednisolone due to clinical symptoms. In September 2017, the patient developed a solitary lymph node metastasis next to the right atrium, for which he received stereotactic radiotherapy. The systemic treatment with Pembrolizumab was replaced by the PD-Ll inhibitor Avelumab and is being continued since. The patient has been in complete remission for one year now and the HIV-infection is well-controlled. (C) 2018 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.
Details
Original language | English |
---|---|
Pages | 42-45 |
Number of pages | 4 |
Publication status | Published - Feb 2019 |
Peer-reviewed | Yes |
External IDs
PubMed | 30671549 |
---|---|
Scopus | 85067178015 |
ORCID | /0000-0001-7096-5199/work/147142305 |
ORCID | /0000-0003-4340-9706/work/147143194 |
ORCID | /0009-0001-4054-4024/work/149081670 |
Keywords
Keywords
- Avelumab, Hiv, Immune checkpoint inhibition, Immunotherapy, Merkel cell carcinoma, Pembrolizumab, Radiotherapy, Sarcoidosis